CORAXIS TOPICAL SOLUTION- moxidectin solution

Țară: Statele Unite ale Americii

Limbă: engleză

Sursă: NLM (National Library of Medicine)

Ingredient activ:

MOXIDECTIN (UNII: NGU5H31YO9) (MOXIDECTIN - UNII:NGU5H31YO9)

Disponibil de la:

Bayer HealthCare, LLC Animal Health Division

Calea de administrare:

TOPICAL

Tip de prescriptie medicala:

PRESCRIPTION

Indicații terapeutice:

CORAXIS is indicated for the prevention of heartworm disease caused by Dirofilaria immitis. CORAXIS is also indicated for the treatment and control of the following intestinal parasites: Intestinal Parasite Intestinal Stage Adult Immature Adult Fourth Stage Larvae Hookworm Species Ancylostoma caninum X X X Uncinaria stenocephala X X X Roundworm Species Toxocara canis X X Toxascaris leonina X Whipworm Trichuris vulpis X Do not administer this product orally. (See WARNINGS.) Do not use this product (containing 2.5% moxidectin) on cats.

Rezumat produs:

Applications Per Package 6 x 0.4 mL tubes 6 x 1.0 mL tubes 6 x 2.5 mL tubes 6 x 4.0 mL tubes 6 x 5.0 mL tubes NADA # 141-417, Approved by FDA Made in Italy ©2018 Bayer HealthCare LLC Bayer (reg’d), the Bayer Cross (reg’d) and Coraxis ™ are trademarks of Bayer. 86572354 LV1808 August, 2018 Bayer HealthCare LLC Animal Health Division P.O. Box 390, Shawnee Mission, Kansas 66201 U.S.A.

Statutul autorizaţiei:

New Animal Drug Application

Caracteristicilor produsului

CORAXIS TOPICAL SOLUTION- MOXIDECTIN SOLUTION
BAYER HEALTHCARE, LLC ANIMAL HEALTH DIVISION
----------
CORAXIS
_(MOXIDECTIN)_
TOPICAL SOLUTION FOR DOGS
ONCE-A-MONTH TOPICAL SOLUTION FOR THE PREVENTION OF HEARTWORM DISEASE
CAUSED BY _DIROFILARIA_
_IMMITIS, _AS WELL AS THE TREATMENT AND CONTROL OF INTESTINAL
HOOKWORM, ROUNDWORM AND WHIPWORM
INFECTIONS IN DOGS AND PUPPIES THAT ARE AT LEAST 7 WEEKS OF AGE AND
THAT WEIGH AT LEAST 3 LBS.
WARNING
•
•
•
(SEE CONTRAINDICATIONS, WARNINGS, HUMAN WARNINGS, AND ADVERSE
REACTIONS, FOR MORE
INFORMATION)
CAUTION:
Federal (U.S.A.) Law restricts this drug to use by or on the order of
a licensed veterinarian.
DESCRIPTION:
_CORAXIS™ _(2.5% moxidectin) is a colorless to yellow, ready-to-use
solution packaged in single dose
applicator tubes for topical treatment of dogs. The formulation and
dosage schedule are designed to
provide a minimum of 1.1 mg/lb (2.5 mg/kg) moxidectin based on body
weight.
Moxidectin is a semisynthetic macrocyclic lactone endectocide derived
from the actinomycete
_Streptomycetes cyaneogriseus noncyanogenus. _The chemical name for
moxidectin is [6R,23E,25S(E)]-5-
O-Demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)
milbemycin B.
INDICATIONS:
_CORAXIS _is indicated for the prevention of heartworm disease caused
by _Dirofilaria immitis. CORAXIS_
is also indicated for the treatment and control of the following
intestinal parasites:
INTESTINAL PARASITE
INTESTINAL STAGE
ADULT
IMMATURE
ADULT
FOURTH STAGE
LARVAE
Hookworm
Species
_Ancylostoma_
_caninum_
X
X
X
_Uncinaria_
_stenocephala_
X
X
X
Roundworm
_Toxocara canis_
X
X
TM
DO NOT ADMINISTER THIS PRODUCT ORALLY
FOR THE FIRST 30 MINUTES AFTER APPLICATION ENSURE THAT DOGS CANNOT
LICK THE PRODUCT
FROM APPLICATION SITES ON THEMSELVES OR OTHER TREATED ANIMALS.
CHILDREN SHOULD NOT COME IN CONTACT WITH APPLICATION SITES FOR TWO (2)
HOURS AFTER
APPLICATION.
Species
_Toxascaris_
_leonina_
X
Whipworm
_Trichuris vulpis_
X
CONTRAINDICATIONS:
DO NOT ADMINISTER THIS PRODUCT ORALLY. (SEE WARNINGS.)
DO N